176 related articles for article (PubMed ID: 37104972)
1. A retrospective multicentric study on the effectiveness of intravenous brivaracetam in seizure clusters: Data from the Italian experience.
Orlandi N; d'Orsi G; Pauletto G; Nilo A; Sicurella L; Pescini F; Giglia F; Labate A; Laganà A; Renna R; Cavalli SM; Zummo L; Coletti Moja M; Vollono C; Sabetta A; Ranzato F; Zappulla S; Audenino D; Miniello S; Nazerian P; Marino D; Lattanzi S; Piccioli M; Estraneo A; Zini A; Servo S; Giovannini G; Meletti S; ; Bianchini D; Contardi S; Fasolino A; Fiore GM; Foschi N; Giordano A; Laisa P; Lo Coco D; Maccora S; Magaudda A; Panebianco M; Merli E; Piccirillo G; Pugnaghi M; Ramacciotti L; Vaudano AE; Vitale G; Zaniboni A
Seizure; 2023 May; 108():72-80. PubMed ID: 37104972
[TBL] [Abstract][Full Text] [Related]
2. Intravenous brivaracetam in status epilepticus: A multicentric retrospective study in Italy.
Orlandi N; Bartolini E; Audenino D; Coletti Moja M; Urso L; d'Orsi G; Pauletto G; Nilo A; Zinno L; Cappellani R; Zummo L; Giordano A; Dainese F; Nazerian P; Pescini F; Beretta S; Dono F; Gaudio LD; Ferlisi M; Marino D; Piccioli M; Renna R; Rosati E; Rum A; Strigaro G; Giovannini G; Meletti S; ; Cavalli SM; Contento M; Cottone S; Di Claudio MT; Florindo I; Guadagni M; Kiferle L; Lazzaretti D; Lazzari M; Coco DL; Pradella S; Rikani K; Rodorigo D; Sabetta A; Sicurella L; Tontini V; Turchi G; Vaudano AE; Zanoni T
Seizure; 2021 Mar; 86():70-76. PubMed ID: 33561784
[TBL] [Abstract][Full Text] [Related]
3. Real-life evidence about the use of intravenous brivaracetam in urgent seizures: The BRIV-IV study.
Villanueva V; Rodriguez-Osorio X; Juiz-Fernández Á; Sayas D; Hampel K; Castillo A; Montoya J; Garcés M; Campos D; Rubio-Nazábal E; Fernández-Cabrera A; Gifreu A; Santamarina E; Hernández Pérez G; Falip M; Parejo-Carbonell B; García-Morales I; Martínez AB; Massot M; Asensio M; Giménez J; Guillén V; Ruiz-Giménez J; Chavarria B; Rocamora R; Escalza I
Epilepsy Behav; 2023 Oct; 147():109384. PubMed ID: 37634373
[TBL] [Abstract][Full Text] [Related]
4. Randomized open-label trial of intravenous brivaracetam versus lorazepam for acute treatment of increased seizure activity.
Szaflarski JP; Sadek A; Greve B; Williams P; Varner JA; Moseley BD
Epilepsy Behav; 2020 Aug; 109():107127. PubMed ID: 32417382
[TBL] [Abstract][Full Text] [Related]
5. Safety, tolerability, and efficacy of brivaracetam as adjunctive therapy in patients with focal seizures, generalized onset seizures, or Unverricht-Lundborg disease: An open-label, long-term follow-up trial.
Ben-Menachem E; Baulac M; Hong SB; Cleveland JM; Reichel C; Schulz AL; Wagener G; Brandt C
Epilepsy Res; 2021 Feb; 170():106526. PubMed ID: 33461041
[TBL] [Abstract][Full Text] [Related]
6. Brivaracetam add-on treatment in pediatric patients with severe drug-resistant epilepsy: Italian real-world evidence.
Russo A; Pruccoli J; Cesaroni CA; Belotti LMB; Zenesini C; Bonanni P; Boni A; Cesaroni E; Coppola G; Cordelli DM; Danieli A; Mancardi MM; Marchese F; Matricardi S; Messana T; Nocera GM; Operto FF; Pellino G; Reina F; Vanadia F; Verrotti A; Striano P
Seizure; 2022 Nov; 102():120-124. PubMed ID: 36223675
[TBL] [Abstract][Full Text] [Related]
7. BRIVEST: A 'real-world' observational, single-centre study investigating the efficacy, safety and tolerability of Brivaracetam.
Naddell S; Manuel M; Cavill R; White P; Sieradzan K
Epilepsy Behav; 2023 Jan; 138():108985. PubMed ID: 36442261
[TBL] [Abstract][Full Text] [Related]
8. Postmarketing experience with brivaracetam in the treatment of epilepsies: A multicenter cohort study from Germany.
Steinig I; von Podewils F; Möddel G; Bauer S; Klein KM; Paule E; Reif PS; Willems LM; Zöllner JP; Kunz R; Runge U; Kurlemann G; Schubert-Bast S; Rosenow F; Strzelczyk A
Epilepsia; 2017 Jul; 58(7):1208-1216. PubMed ID: 28480518
[TBL] [Abstract][Full Text] [Related]
9. Adjunctive brivaracetam for uncontrolled focal and generalized epilepsies: results of a phase III, double-blind, randomized, placebo-controlled, flexible-dose trial.
Kwan P; Trinka E; Van Paesschen W; Rektor I; Johnson ME; Lu S
Epilepsia; 2014 Jan; 55(1):38-46. PubMed ID: 24116853
[TBL] [Abstract][Full Text] [Related]
10. Efficacy, retention, and safety of brivaracetam in adult patients with genetic generalized epilepsy.
Fonseca E; Guzmán L; Quintana M; Abraira L; Santamarina E; Salas-Puig X; Toledo M
Epilepsy Behav; 2020 Jan; 102():106657. PubMed ID: 31731108
[TBL] [Abstract][Full Text] [Related]
11. The efficacy and tolerability of adjunctive brivaracetam for the treatment of adult epilepsy: An Australian multi-center retrospective real-world observational cohort study.
Halliday AJ; Vogrin S; Ignatiadis S; Gillinder L; Jones D; Kiley M; Kwan P; Seneviratne U; Somerville E; Whitham E;
Epilepsy Behav; 2023 Aug; 145():109287. PubMed ID: 37336131
[TBL] [Abstract][Full Text] [Related]
12. The real-world effectiveness of intravenous brivaracetam as a second-line treatment in status epilepticus.
Martellino C; Laganà A; Atanasio G; Lamanna F; Attardo S; Cascino S; De Luca M; Pardeo O; Giacobbe G; Tripepi G; Roberti R; Granata F; Morace C; Russo E; Labate A
Epilepsy Behav; 2023 Nov; 148():109464. PubMed ID: 37839249
[TBL] [Abstract][Full Text] [Related]
13. Use of brivaracetam in genetic generalized epilepsies and for acute, intravenous treatment of absence status epilepticus.
Strzelczyk A; Kay L; Bauer S; Immisch I; Klein KM; Knake S; Kowski A; Kunz R; Kurlemann G; Langenbruch L; Möddel G; Müller-Schlüter K; Reif PS; Schubert-Bast S; Steinhoff BJ; Steinig I; Willems LM; von Podewils F; Rosenow F
Epilepsia; 2018 Aug; 59(8):1549-1556. PubMed ID: 29943451
[TBL] [Abstract][Full Text] [Related]
14. Brivaracetam as add-on treatment in patients with post-stroke epilepsy: real-world data from the BRIVAracetam add-on First Italian netwoRk Study (BRIVAFIRST).
Lattanzi S; Canafoglia L; Canevini MP; Casciato S; Irelli EC; Chiesa V; Dainese F; De Maria G; Didato G; Gennaro GD; Falcicchio G; Fanella M; Ferlazzo E; Gangitano M; La Neve A; Mecarelli O; Montalenti E; Morano A; Piazza F; Pizzanelli C; Pulitano P; Ranzato F; Rosati E; Tassi L; Di Bonaventura C;
Seizure; 2022 Apr; 97():37-42. PubMed ID: 35320736
[TBL] [Abstract][Full Text] [Related]
15. Brivaracetam efficacy and tolerability in clinical practice: A UK-based retrospective multicenter service evaluation.
Adewusi J; Burness C; Ellawela S; Emsley H; Hughes R; Lawthom C; Maguire M; McLean B; Mohanraj R; Oto M; Singhal S; Reuber M
Epilepsy Behav; 2020 May; 106():106967. PubMed ID: 32179501
[TBL] [Abstract][Full Text] [Related]
16. Adjunctive brivaracetam in focal and generalized epilepsies: A single-center open-label prospective study in patients with psychiatric comorbidities and intellectual disability.
Foo EC; Geldard J; Peacey C; Wright E; Eltayeb K; Maguire M
Epilepsy Behav; 2019 Oct; 99():106505. PubMed ID: 31493736
[TBL] [Abstract][Full Text] [Related]
17. Long-term efficacy, tolerability, and retention of brivaracetam in epilepsy treatment: A longitudinal multicenter study with up to 5 years of follow-up.
Strzelczyk A; Zaveta C; von Podewils F; Möddel G; Langenbruch L; Kovac S; Mann C; Willems LM; Schulz J; Fiedler B; Kurlemann G; Schubert-Bast S; Rosenow F; Beuchat I
Epilepsia; 2021 Dec; 62(12):2994-3004. PubMed ID: 34608628
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the effectiveness and tolerability of perampanel and brivaracetam: a real-world, observational, retrospective study.
Liguori C; Manfredi N; Renna R; Izzi F; Pagliuca M; Pagliuca F; Mercuri NB; Fabio P
Epileptic Disord; 2020 Jun; 22(3):309-316. PubMed ID: 32540833
[TBL] [Abstract][Full Text] [Related]
19. Retention, efficacy, tolerability, and quality of life during long-term adjunctive brivaracetam treatment by number of lifetime antiseizure medications: A post hoc analysis of phase 3 trials in adults with focal seizures.
Brandt C; Dimova S; Elmoufti S; Laloyaux C; Nondonfaz X; Klein P
Epilepsy Behav; 2023 Jan; 138():108967. PubMed ID: 36435010
[TBL] [Abstract][Full Text] [Related]
20. Acute and long-term effects of brivaracetam and brivaracetam-diazepam combinations in an experimental model of status epilepticus.
Niquet J; Suchomelova L; Thompson K; Klitgaard H; Matagne A; Wasterlain C
Epilepsia; 2017 Jul; 58(7):1199-1207. PubMed ID: 28597912
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
